Some effects of the genes at 20q11-q13.32 analyzed in this study may be tumor-specific, as suggested by the findings of Moreira et al. [142] and Chen et al. [143] of associations of BLCAP protein expression and promoter methylation levels with survival of bladder cancer patients, which were consistent with our analysis of drug response in pancancer cell lines. The gene discussed is BLCAP; the disease is urinary bladder carcinoma.